These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 7768600)
1. High- and low-infectivity phenotypes of clonal populations of in vitro-cultured Borrelia burgdorferi. Norris SJ; Howell JK; Garza SA; Ferdows MS; Barbour AG Infect Immun; 1995 Jun; 63(6):2206-12. PubMed ID: 7768600 [TBL] [Abstract][Full Text] [Related]
2. Correlation between plasmid content and infectivity in Borrelia burgdorferi. Purser JE; Norris SJ Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13865-70. PubMed ID: 11106398 [TBL] [Abstract][Full Text] [Related]
3. Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1. Labandeira-Rey M; Skare JT Infect Immun; 2001 Jan; 69(1):446-55. PubMed ID: 11119536 [TBL] [Abstract][Full Text] [Related]
4. Analysis of mechanisms associated with loss of infectivity of clonal populations of Borrelia burgdorferi B31MI. McDowell JV; Sung SY; Labandeira-Rey M; Skare JT; Marconi RT Infect Immun; 2001 Jun; 69(6):3670-7. PubMed ID: 11349029 [TBL] [Abstract][Full Text] [Related]
5. Dissociation of infectivity and pathogenicity in Borrelia burgdorferi. Thomas V; Anguita J; Samanta S; Rosa PA; Stewart P; Barthold SW; Fikrig E Infect Immun; 2001 May; 69(5):3507-9. PubMed ID: 11292785 [TBL] [Abstract][Full Text] [Related]
6. Loss of pathogenic potential after cloning of the low-passage Borrelia burgdorferi ZS7 tick isolate: a cautionary note. Siebers A; Zhong W; Wallich R; Simon MM Med Microbiol Immunol; 1999 Dec; 188(3):125-30. PubMed ID: 10776842 [TBL] [Abstract][Full Text] [Related]
7. Correlation of plasmids with infectivity of Borrelia burgdorferi sensu stricto type strain B31. Xu Y; Kodner C; Coleman L; Johnson RC Infect Immun; 1996 Sep; 64(9):3870-6. PubMed ID: 8751941 [TBL] [Abstract][Full Text] [Related]
8. Effects of vlsE complementation on the infectivity of Borrelia burgdorferi lacking the linear plasmid lp28-1. Lawrenz MB; Wooten RM; Norris SJ Infect Immun; 2004 Nov; 72(11):6577-85. PubMed ID: 15501789 [TBL] [Abstract][Full Text] [Related]
9. Maintenance of infective Borrelia burgdorferi Sh-2-82 in 4% oxygen - 5% carbon dioxide in vitro. Austin FE Can J Microbiol; 1993 Dec; 39(12):1103-10. PubMed ID: 8131108 [TBL] [Abstract][Full Text] [Related]
10. Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein. Norris SJ; Carter CJ; Howell JK; Barbour AG Infect Immun; 1992 Nov; 60(11):4662-72. PubMed ID: 1398980 [TBL] [Abstract][Full Text] [Related]
11. Plasmid stability during in vitro propagation of Borrelia burgdorferi assessed at a clonal level. Grimm D; Elias AF; Tilly K; Rosa PA Infect Immun; 2003 Jun; 71(6):3138-45. PubMed ID: 12761092 [TBL] [Abstract][Full Text] [Related]
12. Variation in antigenicity and infectivity of derivatives of Borrelia burgdorferi, strain B31, maintained in the natural, zoonotic cycle compared with maintenance in culture. Golde WT; Dolan MC Infect Immun; 1995 Dec; 63(12):4795-801. PubMed ID: 7591138 [TBL] [Abstract][Full Text] [Related]
13. BBE02 disruption mutants of Borrelia burgdorferi B31 have a highly transformable, infectious phenotype. Kawabata H; Norris SJ; Watanabe H Infect Immun; 2004 Dec; 72(12):7147-54. PubMed ID: 15557639 [TBL] [Abstract][Full Text] [Related]
14. Population dynamics of a naturally occurring heterogeneous mixture of Borrelia burgdorferi clones. Hofmeister EK; Glass GE; Childs JE; Persing DH Infect Immun; 1999 Nov; 67(11):5709-16. PubMed ID: 10531219 [TBL] [Abstract][Full Text] [Related]
15. Analysis of supercoiled circular plasmids in infectious and non-infectious Borrelia burgdorferi. Simpson WJ; Garon CF; Schwan TG Microb Pathog; 1990 Feb; 8(2):109-18. PubMed ID: 2348778 [TBL] [Abstract][Full Text] [Related]
16. Identification of potential virulence determinants by Himar1 transposition of infectious Borrelia burgdorferi B31. Botkin DJ; Abbott AN; Stewart PE; Rosa PA; Kawabata H; Watanabe H; Norris SJ Infect Immun; 2006 Dec; 74(12):6690-9. PubMed ID: 17015459 [TBL] [Abstract][Full Text] [Related]
17. Retention of B. burgdorferi pathogenicity and infectivity after multiple passages in a co-culture system. Güner ES Experientia; 1994 Jan; 50(1):54-9. PubMed ID: 8293801 [TBL] [Abstract][Full Text] [Related]
18. Population dynamics of a heterogeneous Borrelia burgdorferi B31 strain in an experimental mouse-tick infectious cycle. Elias AF; Schmutzhard J; Stewart PE; Schwan TG; Rosa P Wien Klin Wochenschr; 2002 Jul; 114(13-14):557-61. PubMed ID: 12422601 [TBL] [Abstract][Full Text] [Related]
19. Borrelia burgdorferi gene expression in vivo and spirochete pathogenicity. Anguita J; Samanta S; Revilla B; Suk K; Das S; Barthold SW; Fikrig E Infect Immun; 2000 Mar; 68(3):1222-30. PubMed ID: 10678930 [TBL] [Abstract][Full Text] [Related]
20. Isolation of moderately infectious Borrelia burgdorferi sensu stricto from attenuated cultures by using complement-mediated, antibody-dependent lysis selection technique in a mammalian tissue co-culture system. Sen E; Schell RF Microbes Infect; 2003 Aug; 5(10):869-78. PubMed ID: 12919855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]